Results 221 to 230 of about 308,418 (340)

Polysaccharide‐Coated ETCA Nanoparticles Containing the Methoxyl Substituted Indole‐Thiazole Derivative and Their Antiproliferative Activity in Breast Cancer Cells

Journal of Applied Polymer Science, EarlyView.
ABSTRACT Indole and thiazole derivatives have garnered significant attention due to their potent antitumor activities. Encapsulation of such derivatives into polymeric nanoparticles offers several advantages, including improved molecular stability and targeted delivery to tumor sites, thereby enhancing their antineoplastic potential.
José Cleberson Santos Soares, Iago Dillion Lima Cavalcanti, Iranildo José da Cruz‐Filho, Mariane Cajubá de Britto Lira Nogueira, Maria do Carmo Alves de Lima   +4 more
wiley   +1 more source

m6A reader IGF2BP2 mediates paclitaxel resistance in esophageal squamous cell carcinoma via FOXM1 mRNA stabilization. [PDF]

Oncol Rep
Ren S, Wu J, Zhang L, Guan G, Jiang W.
europepmc   +1 more source

A Phase II Double-Blind Randomized Study of the Simultaneous Administration of Recombinant Human Interleukin-6 and Recombinant Human Granulocyte Colony-Stimulating Factor Following Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer

, 1999
Howard S. Höchster, James L. Speyer, John Mandeli, Carolyn D. Runowicz, Scott Wadler, Greg Berk, Robert C. Wallach, James F. Holland   +7 more
openalex   +1 more source

A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer [PDF]

, 2000
Christian Kollmannsberger, D. Quietzsch, Christian Haag, Thomas Lingenfelser, M. Schroeder, J.T. Hartmann, W. Baronius, V. Hempel, Michael Clemens, Lothar Kanz, Carsten Bokemeyer   +10 more
openalex   +1 more source

X‐ray controlled release strategy in cancer therapy

BMEMat, EarlyView.
A comprehensive review on the design principles and current strategies of X‐ray stimulated release systems in cancer therapy, focusing on the X‐ray responsive functional groups and materials as well as discussing the advantages and current challenges of X‐ray controlled release systems in cancer therapy.
Yiling Ruan, Hongxiang Huang, Huihui Liu, Jinglang Gong, Changjun Li, Xiaolian Sun   +5 more
wiley   +1 more source

Cytotoxicity of Esculetin Compared with Vinblastine and Paclitaxel in PC-3 Prostate Cancer Cells. [PDF]

Curr Oncol
García-Pérez AI, Rubio V, Herráez A, Puebla L, Diez JC.   +4 more
europepmc   +1 more source

2035 A phase I study of paclitaxel as a radiation sensitizer for the treatment of non-small cell lung cancer and mesothelioma

, 1995
Laurie L. Herscher, S.M. Hahn, Harvey I. Pass, Barbara K. Temeck, Barry R. Goldspiel, J. E. Cook, James B. Mitchell, J. Liehmann   +7 more
openalex   +1 more source

Modulation of paclitaxel resistance by annexin IV in human cancer cell lines [PDF]

, 2000
Edward K. Han, Sajid Khan Tahir, Sajeev Cherian, Nathan Collins, S-C Ng   +4 more
openalex   +1 more source

Innovative transdermal drug delivery systems: Benefits, challenges, and emerging application

BMEMat, EarlyView.
The graphical abstract illustrates the diverse nanostructures employed in transdermal drug delivery systems, highlighting their unique mechanisms to penetrate the intricate layers of skin. It provides a detailed representation of the skin's complex anatomy, emphasizing the challenges posed by its barrier properties.
Syed Waqas Ali Shah, Xingxing Li, Hao Yuan, Huiling Shen, Shaohao Quan, Guifang Pan, Muhammad Ishfaq, Abid Ullah Shah, Hanhan Xie, Jundong Shao   +9 more
wiley   +1 more source

Notoginsenoside R1, a Metabolite from <i>Panax notoginseng</i>, Prevents Paclitaxel-Induced Peripheral Neuropathic Pain in Mice. [PDF]

Molecules
Al-Musailem M, Masocha W, Al-Romaiyan A.
europepmc   +1 more source